Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease

Journal of Infectious Diseases

Volumn 196, Issue 4, 2007, Pages 528-536

  Schvoerer, Evelyne ^a,c,d,f   Soulier, Eric ^c   Royer, Cathy ^c   Renaudin, Anne Catherine ^a   Thumann, Christine ^c   Fafi Kremer, Samira ^a,c,d   Brignon, Nicolas ^c   Doridot, Stéphane ^c   Meyer, Nicolas ^a   Pinson, Patricia ^e   Ellero, Bernard ^b   Woehl Jaegle, Marie Lorraine ^b   Meyer, Carole ^b   Wolf, Philippe ^b   Zachary, Pierre ^a   Baumert, Thomas ^c,d   Stoll Keller, Françoise ^a,c,d  

^a HÔPITAL CIVIL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e HÔPITAL PELLEGRIN   (France)

^f Institut de virologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; ENVELOPE GENE; FEMALE; GENOTYPE; GRAFT INFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TH1 CELL; TH2 CELL; VIRUS MORPHOLOGY; VIRUS STRAIN;

ADULT; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CYTOKINES; EVOLUTION, MOLECULAR; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 34547616165     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519691     Document Type: Article

References (29)

1. McCaughan GW, Zekry A. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 2004; 40:368-74.
2. Terrault NA, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 2006; 12:1192-204.
3. Barth H, Schnober EK, Zhang F, et al. Viral and cellular determinants of hepatitis C virus envelope-heparan sulfate interaction. J Virol 2006; 80:19579-90.
4. Schirren CA, Jung M, Worzfeld T, et al. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transpl 2000; 6:222-8.
5. Zekry A, Bishop GA, Bowen DG, et al. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl 2002; 8:292-301.
6. Neau D, Jouvencel AC, Legrand E, et al. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients. J Med Virol 2003; 71:41-8.
7. Farci P, Shimoda A, Coiana A, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288:339-44.
8. Hughes MG Jr, Rudy CK, Chong TW, et al. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Liver Transpl 2004; 10:208-16.
9. Feliu A, Gay E, Garcia-Retortillo M, Saiz JC, Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004; 10:1131-9.
10. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001; 75:5703-10.
11. Smith DB. Evolution of the hypervariable region of hepatitis C virus. J Viral Hepat 1999; 6(Suppl 1):41-6.
12. Callens N, Ciczora Y, Bartosch B, et al. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 2005; 79:15331-41.
13. Ben-Ari Z, Pappo O, Druzd T, et al. Role of cytokine gene polymorphism and hepatic transforming growth factor β1 expression in recurrent hepatitis C after liver transplantation. Cytokine 2004; 27:7-14.
14. Kusumoto K, Uto H, Hayashi K, et al. Interleukin-10 or tumor necrosis factor-α polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 2006; 34:24-31.
15. Schvoerer E, Thumann C, Spohrer S, et al. Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence. J Med Virol 2006; 78:1070-5.
16. Gaud U, Langer B, Petropoulou T, Thomas HC, Karayiannis P. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J Med Virol 2003; 69:350-6.
17. Mao Q, Ray SC, Laeyendecker O, et al. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol 2001; 75:3259-67.
18. Silini E, Belli L, Brambilla S, et al. Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis. Liver Transpl 2003; 9:1040-7.
19. Pawlotsky JM. Hepatitis C virus population dynamics during infection. Curr Top Microbiol Immunol 2006; 299:261-84.
20. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117:619-25.
21. Prati D, Shiftman ML, Diago M, et al. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol 2006; 44:679-85.
22. Sullivan DG, Wilson JJ, Carithers RL Jr, Perkins JD, Gretch DR. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998; 72:10036-43.
23. Sanchez-Fueyo A, Gimenez-Barcons M, Puig-Basagoiti F, et al. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001; 65:266-75.
24. Lyra AC, Fan X, Lang DM, et al. Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 2002; 123:1485-93.
25. Doughty AL, Painter DM, McCaughan GW. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J Hepatol 2000; 32:126-34.
26. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002; 185:417-21.
27. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187:1951-8.
28. Ducoulombier D, Roque-Afonso AM, Di Liberto G, et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39:817-25.
29. Pal S, Sullivan DG, Kim S, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006; 130:1107-1.